Genetic alterations of TRAF2 or TRAF3 are observed in subsets of human B-cell lymphomas and B cell-specific deletion of TRAF3 led to lymphoma development in aged mice. This evidence concerns the gene TRAF3 and B-cell non-Hodgkin lymphoma.